Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

The FANTOM II trial is intended to assess safety and performance of the Fantom Bioresorbable Coronary Scaffold in native coronary arteries.

Clinical Study Identifier: NCT02539966

Start Over

Chermside, Australia

View all locations

Recruitment Status: Open

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Powered by